Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes
Viruses · 2025
DOI: 10.3390/v17050684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Magnus Illum Dalegaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital, 2650 Hvidovre, Denmark. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B virus, Epitopes, T-Lymphocyte, Evolution, Molecular. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Sygeforsikringen "Danmark, The Danish Cancer Society.
Abstract (Originalsprache)
The impact of hepatitis B virus (HBV) diversity and evolution on disease progression is not well-understood. This study aims to compare intra-individual viral evolution in two groups of chronic hepatitis B (CHB) patients, using antiviral treatment initiation as a measure of lack of immunological control. From the Danish Database for Hepatitis B and C (DANHEP), 25 CHB patients were included; 14 with antiviral treatment initiation (TI group), and 11 without (NTI group). For each patient, three serial plasma samples taken before potential treatment initiation were selected. HBV DNA was amplified by PCR and analyzed by next-generation sequencing. HBV DNA and alanine transaminase were elevated in the TI group throughout the study period. Significantly higher substitution rates in the NTI group versus the TI group were found both within the viral population and at consensus level. Putative predicted CD8+ T cell epitopes contained significantly more substitutions in the NTI group. Genome-wide association analysis revealed several amino acid residues in the HBV genome associated with treatment initiation. This study shows that HBV has a higher rate of substitutions in CHB patients not requiring treatment. This could be linked to host immune pressure leading to disease control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Copenhagen University Hospital, 2650 Hvidovre, Denmark.
- Copenhagen Hepatitis C Program (COHEP), Department of Infectious Diseases, Copenhagen University Hospital, 2650 Hvidovre, Denmark.
- Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.
- Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2300 Copenhagen, Denmark.
ORCID-Profile: Anders Gorm Pedersen, Signe Bollerup, Jens Bukh, Nina Weis
Förderung
- Novo Nordisk Foundation
- Sygeforsikringen "Danmark
- The Danish Cancer Society
- Sygeforsikringen “Danmark”
- Danish Cancer Society
- Novo Nordisk Foundation BRIDGE research fellowship
- Danish National Research Foundation
Zitieren
APA
Dalegaard, M. I., Winckelmann, A., Fahnøe, U., Underwood, A. P., Pedersen, A. G., Bollerup, S., Bukh, J., & Weis, N. (2025). Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes. Viruses. https://doi.org/10.3390/v17050684
Vancouver
Dalegaard MI, Winckelmann A, Fahnøe U, Underwood AP, Pedersen AG, Bollerup S, et al. Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes. Viruses. 2025. doi:10.3390/v17050684
BibTeX
@article{Dalegaard2025,
author = {Dalegaard, Magnus Illum and Winckelmann, Anni and Fahnøe, Ulrik and Underwood, Alexander P and Pedersen, Anders Gorm and Bollerup, Signe and Bukh, Jens and Weis, Nina},
title = {Higher Rates of Viral Evolution in Chronic Hepatitis B Patients Linked to Predicted T Cell Epitopes},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050684}
}
EUVIMED